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Determinants of health – related quality of life in patients with            
inflammatory bowel diseases 
 
Odrednice kvalitete života kod oboljelih od upalnih bolesti crijeva 
 




The aim is to examine the contribution of socio-demographic, medical, and psychological factors in 
predicting health related quality of life (HRQoL) in patients with inflammatory bowel diseases (IBD) and to 
examine the differences between those with Crohn's disease and ulcerative colitis, regarding psychosocial 
factors and quality of life.  
Methods. Data from 90 participants with Crohn's disease and 63 participants with ulcerative colitis were 
collected using HBI, SCCAI, HADS, and shortened versions of SIBDQ, SS – A, and COPE, and the measure 
of self-evaluated disease activity. Data were analyzed by multiple hierarchical regression and discriminant 
analysis.  
The results of socio-demographic, medical and psychological factors accounted for 66% of variance of 
HRQoL in participants with IBD, with disease activity, and levels of anxiety and depression being the 
strongest independent predictors. Higher disease activity and higher level of psychological disturbances were 
related to lower HRQoL. Differences between the two diagnostic groups were found in disease activity 
assessments and disengagement, with participants suffering from Crohn's disease indicating lower levels of 
disease activity, using disengagement as a coping strategy less often.  
Conclusion. The findings on independent contribution of psychological disturbances in predicting the 
HRQoL, positive correlation of anxiety and depression with disease activity, and high representation of 
clinically relevant anxiety (27.5%) and depression (10.5%) in the sample with a low representation of 
participants with severe, active phase of disease point towards a need for routine screening for anxiety and 
depression in IBD patients and inclusion of specific psychological support in IBD treatment. 




Cilj. Ispitati doprinos sociodemografskih, medicinskih i psiholoških čimbenika u predviđanju kvalitete 
života povezane sa zdravljem kod oboljelih od upalnih bolesti crijeva, te ispitati razlike u psihosocijalnim 
čimbenicima i kvaliteti života između oboljelih od Crohnove bolesti i ulceroznog kolitisa. 
Metode. Prikupljeni su podaci od 90 sudionika s Crohnovom bolešću i 63 sudionika s ulceroznim 
kolitisom, pomoću upitnika HBI, SCCAI, HADS; skraćenih verzija upitnika SIBDQ, SS – A i COPE, te mjere 
samoprocjene aktivnosti bolesti. Podaci su analizirani pomoću multiple hijerarhijske regresijske analize i 
diskriminacijske analize.  
Rezultati. Ispitani sociodemografski, medicinski i psihološki čimbenici objasnili su 66% varijance 
kvalitete života povezane sa zdravljem kod oboljelih od upalnih bolesti crijeva, pri čemu su se aktivnost 
bolesti, te stupanj anksioznosti i depresivnosti pokazali najsnažnijim nezavisnim prediktorima. Kvaliteta 
života oboljelih pokazala se manjom, što su aktivnost upalnih bolesti crijeva i razina psiholoških smetnji veće. 
Razlike između dviju dijagnostičkih skupina nađene su u samoprocjeni aktivnosti bolesti i dezangažmanu, pri 
čemu su oboljeli od Crohnove bolesti izvještavali o nižim razinama aktivnosti bolesti i rjeđem korištenju 
dezangažmana kao strategije suočavanja sa stresom. 
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Zaključak. Nalazi o nezavisnom doprinosu psiholoških smetnji u predviđanju kvalitete života, pozitivnoj 
povezanosti anksioznosti (27.5%) i depresivnosti s aktivnošću bolesti, te visokoj zastupljenosti klinički 
značajne anksioznosti i depresivnosti (10.5%) u uzorku s niskim udjelom sudionika u teškoj aktivnoj fazi 
bolesti, ukazuju na potrebu za rutinskim probirom za anksioznost i depresivnost, te sustavnim pružanjem 
psihološke podrške oboljelima od upalnih bolesti crijeva. 







Inflammatory Bowel Diseases (IBD) are hetero-
geneous disorders resulting from the combination of 
genetic factors, disorders of intestinal motility, visceral 
oversensitivity, disrupted regulation of mucosal immune 
response, changes in bacterial flora and disrupted 
regulation of the axis between the central nervous 
system (CNS) and the enteric nervous system (ENS), 
the so called ''second brain".1-2 The assumed important 
role of psychosocial factors in the development and 
course of IBD, as well as the perceived imbalance 
between the clinical presentations of the disease and 
real disease activity confirmed by laboratory and the 
endoscopic tests,3 are all behind the growing interest 
for measuring health related quality of life (HRQoL) in 
IBD. This should supplement the information on 
physical symptoms with social, emotional, systematic 
and functional characteristics, leading to better com-
parability with overall self-evaluation of participants' 
health.4  
The role of psychological factors in development 
and course of the IBD is very complex and still            
not fully clarified.5 The general opinion is that 
psychological factors (personality, psychological stress, 
depression and anxiety) contribute to exacerbation of 
IBD, but not to their etiology or development,5-8 with 
the exception of the finding of Kurina et al., that 
depression and anxiety antecede the development of 
ulcerative colitis (UC), but not  Crohn's disease (CD),9 
and contrary findings of Ananthakrishnan et al. on 
depression10 as the antecedent psychological disorders 
in CD, but not in UC. Research on contribution of 
biopsychosocial factors to the prediction of HRQoL in 
participants with IBD showed that disease activity,11,12-16 
intake of systemic corticosteroids and immuno-
suppressants, disease relapses, presence of extra-
intestinal manifestations of disease,17 presence of 
symptoms resembling irritable bowel syndrome 
(IBS),18-21 anxiety and depression,11,12,22-23 depressive 
coping with stress24-26 and emotion focused coping 
with stress27 were all negatively correlated, while 
social support23,27-28 was positively correlated, with the 
quality of life (QoL). On the other hand, findings on 
relations between illness duration, level of education, 
gender, problem focused coping with stress, chronic 
psychological stress, and acute everyday stress with 
QoL in patients with IBD are contradictory. Some 
studies found longer illness duration,13-14 higher level 
of education13,29 and male gender13,23,29-30 to be related 
with better HRQoL, while other found no correlation 
of illness duration22,31 and level of education with 
quality of life,11,30-31 and higher general satisfaction and 
HRQoL in females.11 There are findings of the positive 
correlation of problem focused coping with the quality 
of life,27 but also those of the positive correlation of 
active coping with stress and intense concerns, as well 
as higher number of somatic complaints, which is 
explained by inadequacy of active coping in 
uncontrollable and unpredictable diseases as are IBD 
or by the possibility that participants with a higher 
amount of concerns are more frequently involved in 
active information seeking.32 Some studies show a 
correlation between stressful life events and a higher 
risk of later relapse of IBD,33-35 while in others this 
relation was not significant.36-41 Similarly, a positive 
correlation of acute everyday stress and self-evaluated 
activity of IBD, even after controlling for major life 
events, was established in some studies,42-43 while in 
some no such relation was found.38 In addition, one 
study shows that exacerbation was not associated with 
stressful life events or short-term perceived stress, but 
that long-term perceived stress increases the risk of 
later exacerbation,38 in line with other studies showing 
the association between perceived stress and disease 
activity assessed both by presence of symptoms44 and 
presence of inflammation.45 Furthermore, a most recent 
study found prospective bidirectional relationships 
between perceived stress and IBD symptom reporting 
but no relationship between perceived stress and 
presence of inflammatory disease activity as assessed 
by fecal calprotectin,46 raising further questions in 
debates over the role of stress in IBD. Finally, several 
studies found early adverse life events to be a major 
risk factor for the adult onset and severity of IBD and 
IBS.47-50 
Analyses of the differences in biopsychosocial 
factors between patients with CD and UC also show 
contradictory findings. While some studies found no 
differences in levels of anxiety19,22 and depression12,19,22 
between the two diagnostic groups, other studies    
point towards a higher level of depression3,51 and 
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anxiety3,26,51-52 in CD. Furthermore, some found an 
equally disrupted quality of life in both diagnostic 
groups,12,13,15,22 and other the poorer quality of life in 
the CD group14,51,53 attributed to more severe disease 
type.54  
With the purpose of further clarification of the 
complex role of biopsychosocial factors of IBD, the 
aim of this research was to examine the relative 
contribution of socio-demographic (gender, age, socio-
economic status), medical (diagnosis, disease activity, 
illness duration) and psychological factors (anxiety, 
depression, strategies of coping with stress, perceived 
social support) to the prediction of HRQoL in patients 




Participants and procedure 
 
The questionnaires were filled out by 202 
participants. However, 49 were excluded due to 
missing data and further 7 due to their diagnosis of 
intermediate colitis. Therefore, analyses were 
performed on the results of 153 participants, 90 of 
them with CD and 63 with UC. The majority of the 
participants were members of the Croatian Crohn's and 
Ulcerative Colitis Association (HUCUK). Participants 
were invited to join the research via written invitation 
sent to their home address, the invite published on 
HUCUK's website, or an e–mail invitation by using the 
method of snowball sampling. The questionnaires 
were filled out online, using the services of Survey 
Monkey platform. The description of the socio-
demographic characteristics of the sample is presented 
in Table 1. 
The overall sample, as well as both subsamples, 
were well balanced regarding gender, age, education 
and income. As can be seen from medical data for both 
subsamples (Table 2), they are also comparable in 
illness duration. However, they differ in the 
distribution of self-evaluated disease activity: the 
largest proportion of participants with CD reported 
being in remission, and significantly more participants 
with UC being in the moderate active phase of the       
disease. 
 
Table 1 Socio-demographic data for the overall sample of patients with inflammatory bowel diseases (N = 153) 
and for subsamples of patients with Crohn's disease (n = 90) and ulcerative colitis (n = 63) 
Tablica 1. Socio-demografski podaci za ukupni uzorak bolesnika s upalnim bolestima crijeva (N = 153) i za 
podvrste bolesnika s Crohnovom bolešću (n = 90) i ulceroznim kolitisom (n = 63) 
 













Male/Muško n 70 44 26 
% 45.8 48.9 41.3 
Female/Žensko n 83 46 37 
% 54.2 51.1 58.7 
 
Age/Dob 
 M 35.07 35.28 34.76 
SD 10.635 11.651 9.069 
Min 15 15 17 





% 2.6 3.3 1.6 
High school 
Srednja škola 
% 55.6 58.9 50.8 
College/Undergraduate  
Viša škola/dodiplomski 
% 12.4 14.4 9.5 
Graduate/diplomirani  % 23.5 17.8 31.7 
Postgraduate 
Poslijediplomski 
%   5.9   5.6   6.4 
Average monthly income per household 
member in HRK 
Prosječan prihod po članu obitelji u HRK 
M 2792 2831 2738 
SD 1746 1651 1885 
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Table 2 Medical data for patients with Crohn's disease (n = 90) and ulcerative colitis (n = 63) 
Tablica 2. Medicinski podaci za pacijente s Crohnovom bolešću (n = 90) i ulceroznim kolitisom (n = 63) 
 





 M 4.01  
 SD 3.636  
 SCCAI 
 M  5.26 





 n 90 63 
 M 2.03 2.56 
 SD 1.086 1.215 
 K-S 2.23** 1.46* 
Remission / Remisija % 41.1 25.4 
Remission with some IBS  
symptoms 
Remisija s ponekim IBS 
simptomima 
% 27.8 25.4 
Mild active phase 
Blago aktivna faza 
% 20 20.6 
Moderate active phase 
Umjereno aktivna faza 
% 8.9 25.4 
Severe active phase 
Teška aktivna faza 
% 2.2 3.2 
Illness duration 
Trajanje bolesti 
 M 9.66 9.27 
 SD 7.594 8.999 
 
HBI: Harvey-Bradshaw Index of Crohn's Disease Activity/ Harvey-Bradshaw Indeks aktivnosti Crohnove bolesti 
SCCAI: Simple Clinical Colitis Activity Index / Indeks aktivnosti jednostavni klonički colitis  
IBS: symptoms resembling irritable bowel syndrome/simptomi slični simptomima razdražljivih crijeva 
K-S: Kolmogorov-Smirnov test for normality of the distribution, * p < 0.05 ** p < 0.01 
K-S: Kolmogorov-Smirnov testiranje normalnosti distribucije  * p < 0.05 ** p < 0.01 
 
 
Both distributions were significantly positively 
asymmetric (K-S = 2.23; p < 0.01 in CD, and K-S = 1.46; 
p < 0.05 in UC), with the majority of participants being in 
remission or very mild phase of the disease, and only 
2.2% participants with CD and 3.2% participants with 
UC evaluating their disease as being in a severe, active 
phase. This is probably the consequence of lower interest 
in severely ill patients for participating in the research, 




The Short Inflammatory Bowel Disease Question-
naire (SIBDQ)55 is a health-related quality of life 
(HRQoL) tool, measuring physical, social, and 
emotional status (score 10-70, poor to good HRQoL).  
Harvey-Bradshaw Index of Crohn's Disease 
Activity (HBI)56 is a simpler version of Crohn's Disease 
Activity Index (CDAI), the research tool for 
quantification of symptoms in subjects with CD, with 
higher total score indicating a higher disease activity. 
Simple Clinical Colitis Activity Index (SCCAI)57 is 
the shortened version of Powell-Tuck Index, a tool for 
quantification of symptoms in patients with UC, with 
higher overall score indicating a higher disease activity.  
Self-evaluation of disease activity. Participants were 
asked to evaluate the activity of their disease during the 
previous two weeks on a 5-point scale: 1 - in remission/ 
inactive; 2 - in remission/inactive, with some symptoms 
resembling irritable bowel syndrome (stomach aches, 
constipation, diarrhea, mucus in excrement, bloating, 
heavy feeling in the stomach after a meal, heartburn, 
but without signs of inflammation or degenerative 
changes); 3 – in the mild active phase (the disease 
symptoms did not interfere with my everyday 
activities); 4 - in the moderate active phase (the disease 
symptoms interfered with my everyday activities); 5 - 
in the severe active phase (the disease symptoms 
disabled me from performing my everyday activities 
and forced me to take a sick leave or be hospitalized).   
Hospital Anxiety and Depression Scale (HADS)58 is 
a self-assessment scale for detecting states of anxiety
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and depression in patients with physical ailments, by 
measuring exclusively emotional states, but not 
somatic symptoms. The result is expressed in two 
scores: anxiety (HADS-A) and depression (HADS-D), 
on a scale from 0 (low levels of anxiety/depression) up 
to 21 (extremely high levels of anxiety/depression). 
Scores ≥ 11 on both subscales are considered clinically 
relevant.  
Scale of Perceived Social Support (Hudek-
Knežević, 1994)59 is a shortened and adapted version 
of the Social Support Appraisals Scale (SS-A). The 
scale measures the participants’ experienced level of 
love, respect and involvement received from their 
family and friends. The total score can range from 0 
(very low level of perceived social support) up to 56 
(very high level of perceived social support).  
Questionnaire for evaluating coping as disposition 
(Hudek-Knežević and Kardum, 1993)60 is a shortened 
and adapted version of Coping Orientation to 
Problems Experienced (COPE). The scores can range 
from 0 to 24 for problem-focused coping, from 0 to 12 
for emotion-focused coping, and from 0 to 24 for 
disengagement. A high score in each of the subscales 
indicates a more frequent usage of that coping style.  
The socio-demographic data on gender, age, level 
of education, average monthly income per household 
member, and medical data on the type of the diagnosis 





Data were analyzed by SPSS (Statistical Package 
for the Social Sciences), version 17. In order to 
determine the biopsychosocial status of the patients 
with IBD, a descriptive statistical analysis was 
performed for both all participants with IBD, and 
subgroups with CD and UC. Discriminant analysis was 
used to determine whether participants with CD and 
UC differed in socio-demographic, medical and 
psychological variables, and in their HRQoL. A 
multiple hierarchical regression analysis was 
performed to examine the contribution of socio-
demographic, medical and psychological factors to the 
prediction of HRQoL in patients with IBD. As the 
discriminant analysis had shown only minimal 
differences in predictor variables between those with 
CD and UC, the regression analysis was performed for 
the whole sample, with diagnosis entered into the 
regression as a predictor. Before conducting the 
regression analysis, inter-correlations of predictors and 
the criterion were examined (Table 4). Self-evaluated 
disease activity was used as a measure of disease 
activity for both subsamples, as it was highly positively 
correlated with both HBI in the subsample with CD           
(r = .70; p < 0.01) and SCCAI in the subsample with 




Quality of life and level of psychological 
disturbances  
 
Table 3 shows the means and standard deviations 
for health – related quality of life, anxiety, depression, 
and coping styles, as well as the proportions of 
participants who scored above the cut-off values for 
anxiety and depression, both in the overall sample and 
in the two subsamples. More than 25% of participants 
in both subsamples scored above the cut-off value for 
anxiety, and 10% of them above the cut-off value for 
depression. 
 
Differences between Crohn's disease and 
ulcerative colitis  
 
The discriminant analysis resulted in one canonical 
discriminant function of low discriminative power. 
The canonical correlation was statistically significant 
(Λ = .87; p < 0.05), and the model explained only 13% 
of variability between groups ( = .15; R2 = .36). A test 
of equality of arithmetic groups within the discriminant 
analysis showed significant differences between 
subgroups with CD and UC: in self-assessed disease 
activity and use of disengagement as a coping strategy: 
participants with CD self-evaluate the disease activity 
as lower than those with UC (F = 7.77; p < 0.01), and 
use disengagement less frequently (F = 6.25; p < 0.05). 
The classification results show low overall predictive 
accuracy of the discriminant function: in cross-
validation only 60.8% of respondents were classified 
correctly into diagnostic groups.  
 
Predicting the quality of life in patients with IBD 
 
As can be seen from Table 4, the highest corre-
lations with HRQoL were found for disease activity, 
anxiety, and depression, all of them negative. Age, 
duration of illness, and emotion-focused coping were 
not correlated with HRQoL, while other predictors 
showed low correlations with the criterion. A high cor-
relation was also found between anxiety and depression. 
In the multiple hierarchical regression analysis 
(Table 5) the sociodemographic variables were entered 
in the first step, and they explained 16% of variance of 
HRQoL, with higher monthly income and male gender 
being statistically significant predictors of a higher 
HRQoL. 
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Table 3 Health related QoL, anxiety, depression, perceived social support, and coping strategies for the whole 
sample of patients with inflammatory bowel diseases (N = 153) and for subsamples of patients with Crohn's 
disease (n = 90) and ulcerative colitis (n = 63) 
Tablica 3. Zdravstveni QoL, anksioznost, depresija, percipirana socijalna podrška i strategije suočavanja za 
cijeli uzorak pacijenata s upalnim bolestima crijeva (N = 153) i za poduzorke bolesnika s Crohnovom bolešću 
(n = 90) i ulceroznim kolitisom (n = 63 ) 
 
  Inflammatory bowel 
diseases 





HRQoL M 48.22 49.56 46.29 
 SD 11.068 10.912 11.091 
HADS-A M 8.67 8.41 9.04 
SD 4.035 4.305 3.616 
HADS-A  
(score ≥ 11) 
n 42 26 16 
% 27.5 28.9 25.4 
HADS-D M 5.34 5.23 5.48 
SD 3.607 3.425 3.875 
HADS-D 
(score ≥ 11) 
n 16 8 8 
% 10.5 8.9 12.7 
Perceived social support  
Percipirana društvena podrška 
M 46.96 47.84 45.67 
SD 8.728 8.361 9.148 
Problem-focused coping 
Suočavanje usmjereno na 
probleme 
M 16.25 16.07 16.52 
SD 3.429 3.505 3.327 
Emotion-focused coping 
Suočavanje usmjereno na emocije 
M 6.46 6.26 6.74 
SD 2.524 2.520 2.523 
Disengagement 
Dezangažiranje 
M 9.10 8.51 9.94 
SD 3.538 3.325 3.688 
 
HRQoL: Health – Related Quality of Life / Kvaliteta života povezana sa zdravljem 
HADS-A: Hospital Anxiety and Depression Scale, anxiety subscale / Bolnička ljestvica anksioznosti i depresije, 
potkategorija anksioznosti 
HADS-D: Hospital Anxiety and Depression Scale, depression subscale / Bolnička ljestvica anksioznosti i depresije, 
potkategorija depresija 
 
Table 4 Inter-correlations of predictor socio-demographic, medical and psychological variables, and their 
correlations with the criterion variable of health-related quality of life in patients with inflammatory bowel 
disease (N = 153) 
Tablica 4. Međusobna povezanost prediktorskih socio-demografskih, medicinskih i psiholoških varijabli i njihova 
povezanost s kriterijskom varijablom zdravstvenog kvaliteta života bolesnika s upalnom bolesti crijeva 
 
 p1 p2 p3 p4 p5 p6 p7 p8 p9 p10 p11 p12 p13 
SIBDQ (k) .20** .02 .17* .35** -.15* -.65** .03 -.61** -.59** .22** .17* -.02 -.27** 
Gender (p1) 
Spol 
 .01 -.06 .09 -.08 -.13 -.07 -.16* -.06 -.11 -.06 -.28** .08 
Age (p2) 
Dob 
  -.01 -.00 -.02 -.05 .47** -.04 -.03 -.10 .15* -.02 -.03 
Education (p3) 
Obrazovanje 
   .31** .14* -.21** -.04 -.01 -.03 -.08 .05 .15* -.04 
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 p1 p2 p3 p4 p5 p6 p7 p8 p9 p10 p11 p12 p13 
Income (p4)  
Prihod 
    -.03 -.28** .00 -.22** -.34** -.01 .06 .02 -.21** 
Diagnosis (p5)  
Dijagnoza 
     .22** -.02 .08 .03 -.12 .06 .09 .20** 
Disease activity (p6) 
Aktivnost bolesti 
      -.02 .25** .32** -.15* -.11 .00 .09 
Illness duration (p7) 
Trajanje bolesti 
       -.06 -.07 .03 .18* -.07 -.01 
HADS-A (p8)         .70** -.23** -.24** .00 .32** 
HADS-D (p9)          -.36** -.25** -.06 .23** 
Social support (p10) 
Društvena podrška 
          .21** .08 -.01 
Coping – problem 
(p11) 
Nošenje s problemom 
           .06 -.02 
Coping – emotions 
(p12) 
Nošenje s emocijama 
            -.12 
Disengagement (p13) 
Dezangažiranje 
             
 
* p < 0 .05 (unidirectional)  ** p < 0.01 (unidirectional) 
SIBDQ: The Short Inflammatory Bowel Disease Questionnaire / Kratak upitnik bolesti upale crijeva 
HADS-A: Hospital Anxiety and Depression Scale, anxiety subscale / Bolnička ljestvica anksioznosti i depresije, 
potkategorija anksioznosti 




Table 5 Results of multiple hierarchical regression analysis with socio-demographic, medical and psychological 
variables as predictors and quality of life as criterion in patients with inflammatory bowel diseases (N = 153)  
Tablica 5. Rezultati višestruke hijerarhijske regresijske analize sa sociodemografskim, medicinskim i psihološkim 






β R2 ΔR2 





Age / Dob .01 
Level of education / Razina obrazovanja .08 
Average monthly income per household member 
Prosječan mjesečni dohodak po članu obitelji 
.31** 
  F (4.148) = 6.91** 








Age / Dob -.03 
Level of education / Razina obrazovanja .01 
Average monthly income per household member 
Prosječan mjesečni dohodak po članu obitelji 
.17* 
Diagnosis / Dijagnoza -.00 
Self-evaluated disease activity 
Samoprocjena aktivnosti bolesti 
-.58** 
Illness duration / Trajanje bolesti .05 
  F (7.145) = 17.78** 
Stamenković Tadić B – Tadinac M. Determinants of health – related quality of life ...  – Med Jad 2020;50(1):17-31 
 
 24










Age / Dob -.03 
Level of education / Razina obrazovanja .05 
Average monthly income per household member 
Prosječan mjesečni dohodak po članu obitelji 
.06 
Diagnosis / Dijagnoza -.01 
Self-evaluated disease activity 
Samoprocjena aktivnosti bolesti 
-.47** 
Illness duration / Trajanje bolesti .01 
Anxiety (HADS–A) /Anksioznost  -.35** 
Depression (HADS–D) / Depresija -.17* 
  F (9.143) = 31.12**  










Age / Dob -.03 
Level of education / Razina obrazovanja .06 
Average monthly income per household member 
Prosječan mjesečni dohodak po članu obitelji 
.05 
Diagnosis / Dijagnoza .01 
Self-evaluated disease activity 
Samoprocjena aktivnosti bolesti 
-.47** 
Illness duration / Trajanje bolesti .01 
Anxiety (HADS–A) /Anksioznost  -.32** 
Depression (HADS–D) / Depresija -.17* 
Perceived social support 
Percipirana socijalna podrška 
.03 
Problem-focused coping 
Suočavanje usmjereno na probleme 
-.01 
Emotion-focused coping 





  F (13.139) = 21.51**  
* p < 0.05 ** p < 0.01 
 
Medical variables entered in the second step 
explained additional 30% of variance of HRQoL, with 
disease activity being the only significant predictor 
from this group - the higher the activity of IBD, the 
lower the quality of life. As expected on the basis of 
the discriminant analysis results, diagnosis (CD vs. 
UC) was not predictive for HRQoL. After introducing 
medical factors into the model, the contribution of 
average monthly income per household member 
remained statistically significant, while gender lost its 
predictive significance.   
Anxiety and depression, entered in the third step, 
explained the additional 20% of variance of HRQoL: 
the higher the level of anxiety and depression, the 
lower the quality of life. After introducing the factors 
of psychological disturbances into the model, the 
contribution of average monthly income per household 
member ceased to be a significant predictor, probably 
due to its shared variance with anxiety and    
depression.  
Perceived social support and coping strategies were 
entered in the fourth step and did not further increase 
the percentage of explained variance of HRQoL. The 
final model explained 67% of variance of HRQoL, 
with self-evaluated disease activity, anxiety and 




Quality of life and level of psychological  
disturbances  
 
Numerous studies established a reduced overall 
quality of life11 and HRQoL11,22,26,52,61-63 in IBD 
patients in comparison to healthy individuals. In our 
overall sample of participants with IBD (Table 3) the 
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HRQoL was slightly below the rates of good HRQoL 
(defined by the SBDQ score > 50),64 suggesting 
moderately impaired quality of life. HRQoL in the CD 
group corresponded to the one determined by Irvine et 
al.,55 while in the UC group was somewhat lower.           
A high variability in HRQoL both in CD (Min = 14, 
Max = 69) and UC group (Min = 17, Max = 68), which 
almost encompassed the overall theoretical span of 
results in the questionnaire, suggests high interpersonal 
differences in clinical manifestation and consequences 
of IBD.   
Depression scores in our total sample were similar 
to those found in a recent study,52 while anxiety scores 
were higher, indicating normal levels of depression 
and borderline abnormal anxiety levels. On the other 
hand, anxiety scores in both CD and UC samples 
corresponded to those determined by Goodhand et 
al.,65 while the depression scores in both diagnostic 
groups were slightly higher. It should be noted that in 
both studies52,65 these anxiety and depression scores in 
patients with IBD were found to be higher than in 
healthy controls. In the light of our findings on 
correlation between psychological disturbances and a 
reduced HRQoL in patients with IBD, also established 
in previous studies,11,12,22-23 especially alarming is the 
fact that 27.5% of participants in our study had a 
clinically relevant score (≥ 11) on the anxiety subscale, 
and 10.5% a clinically relevant score (≥ 11) on 
depression subscale (Table 3). This is in accordance 
with Guthrie et al.’s12 finding that 25.9% of subjects 
with IBD score ≥ 11 on the anxiety or depression 
subscale, as well as with the overall conclusion from 
the recent study that mental health disorders often 
accompany chronic somatic disease with an estimated 
prevalence between 24% and 58%.66 However, when 
interpreting our results, it should be taken into 
consideration that in this study only 2.2% of subjects 
with CD and 3.2% with UC evaluated their disease as 
being in a severe, active phase. Therefore, in more 
representative samples we could expect to find even 
higher proportions of clinically relevant anxiety and 
depression scores, given the findings that frequency of 
anxiety and depression in subjects with IBD during 
relapse reaches up to 80% for anxiety and 60% for 
depression.67 Overall, both our findings and those from 
previous studies warn on a high prevalence of 
psychological disturbances in subjects with IBD, 
higher than in healthy controls even in the absence of 
active inflammation,9,52,65,68-69 and their correlation 
with a reduced HRQoL.11,12,22-23  
In fact, the overall findings suggest the reciprocal 
relation between the symptoms of IBD and 
psychological disturbances through interconnections 
among the psycho-neuro-endocrine-immune systems, 
indicating a self-perpetuating cycle of IBD: the 
incurable and unpredictable course of IBD, their 
severity, and their overall negative impact on QoL lead 
to depression and anxiety, and, in return, psychological 
disturbances lead to worsening of IBD. The significant 
correlations between disease activity and higher level 
of anxiety and depression, also established in previous 
studies,52,65,67,70-73 together with the findings that 
proinflammatory cytokines have the ability to access 
the brain through humoral, neural and cellular 
pathways74 and precipitate depression,75 that intestinal 
microbes might be involved centrally in modulating 
behavior and brain biochemistry,76 that risk of clinical 
depression or anxiety in the year following an IBD 
diagnosis9,77 and after surgery or hospitalization78 
becomes higher, imply that active disease and more 
severe disease course may predispose to psychological 
morbidity. The other way around, the correlations 
between disease activity and psychological 
disturbances, together with the findings that 
psychological disturbances contribute to a higher risk 
for further disease activity,34,70,79-80 poorer adherence to 
treatment81-82 and higher risk for surgery;83 predictive 
value of anxiety and depression for the presence of 
symptoms such as irritable bowel syndrome (IBS) in 
patients with IBD;3,19-20 the findings that mood 
disorders can stimulate production of proinflammatory 
cytokines and thereby adversely affect the course of 
IBD;79 that environmental influences such as stress can 
affect the microbial balance in the gut;76 findings from 
animal studies of the brain-gut axis that depression 
increased susceptibility to experimental colitis84 and 
worsened colitis severity regardless of whether it was 
induced prior to inducing the colitis or following the 
colitis onset; 85-86 all point to anxiety and depression as 
not only the consequences, but also as perpetuating 
factors in IBD.  
The results showing that depression increased 
susceptibility to stressful events through the 
amplification of subjective perception of stress and 
emotional and physiological response to stressful 
events87-89 and that anxiety might induce visceral 
oversensitivity, i.e. heightened sensations and pain 
during abdominal distension, associated with the 
presence of IBS symptoms and disease-related 
distress,90-94 suggest that psychological disturbances 
contribute to the exacerbation of IBD through the 
mediating role of psychological stress and its adverse 
impact on GI functioning. Although research findings 
on the role of stress in IBD have been confusing and 
controversial because of the contradictory results and 
methodological shortcomings,95-96 there is a growing 
amount of evidence supporting the relationship 
between stress and IBD, showing that stress is a 
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triggering47-50,97 and exacerbating38,42-45,98 factor in 
relation to the course and symptoms of IBD, as well as 
one of the determinants of disease relapse,33-35 thus 
providing support for the beliefs of more than 90% of 
patients with IBD that stress influences their disease 
activity.99 Furthermore, the suggested relationship 
between psychological stress and IBD could explain the 
functional bowel symptom exacerbation99 and symptom 
reporting46 in the absence of acute inflammation.  
Overall, these findings on adverse impact of 
psychological disturbances on symptoms of IBD and 
HRQoL suggest that additional attention in IBD 
management should be given to prevalent worries and 
concerns that affect the subjects' personal perceptions 
of disease impact on their social, leisure and working 
life – worry of lack of energy, the sense of lack of 
control, disrupted body image, isolation and fear, 
feeling of beeing a burden to others, feeling dirty, 
etc.100 Furthermore, findings on the brain-gut axis and 
the bidirectional interconnections between psycholo-
gical and GI functioning give new opportunities for 
IBD management suggesting that treating one 
component of the mood-disease interrelationship may 
help to address the other component.101  
 
 
Differences between subjects with Crohn's disease 
and ulcerative colitis 
 
The comparability of subsamples with CD and UC 
regarding age, gender and illness duration is in 
accordance with the findings of epidemiological 
studies.51,77 A low discriminativeness between two 
diagnostic groups (Λ = 0.87; p < .05) is parallel to the 
findings of similar levels of anxiety and depression in 
the two groups12,19,22 and similarly disrupted overall and 
specific quality of life within patients with IBD,12,13,15,22 
although some previous studies established a poorer 
quality of life,14,51,53 and higher level of depression3,51 
and anxiety3,26,51-52 in patients with CD compared to 
those with UC. It should be emphasized that our 
finding on similar HRQoL scores in patients with CD 
and UC contradicts the one from the most recent meta-
analyses of QoL in IBD showing significantly lower 
QoL scores for those with CD versus UC,14 most 
probably because our participants with CD self-
evaluated the disease activity as lower than participants 
with UC. However, our finding of lower self-evaluated 
disease activity in patients with CD needs to be taken 
with reservations because of the non-representa-
tiveness of the samples considering disease activity, 
and statistically dubious role of disease activity in 
discriminatory analysis (because of its statistically 
significant aberration from normal distribution). 
A finding of less frequent use of disengagement as 
a coping strategy in participants with CD contradict 
those of higher frequency of depressive coping with 
stress (self-blame, strategies of avoidance) in patients 
with CD compared to patients with UC.25 Considering 
the possible differences between our subsamples in the 
disease activity, the low reliability of the disengage-
ment subscale (α = 0.49) and inconsistent findings, a 
possible discriminatory value of coping strategies in 
IBD is yet to be determined in further studies.  
In conclusion, the low discriminativeness between 
two diagnostic groups implies that within both the 
research and therapeutic approach the focus should be 
shifted from diagnostic subgroups to heterogeneity of 
clinical manifestations of IBD, because of the high 
interindividual and intraindividual variability in the 
intensity of symptoms, course of the disease and its 
psychosocial consequences, as shown in the high variabi-
lity of HRQol measured in both our subsamples.  
 
Predicting the quality of life in patients with IBD 
 
Our results are in accordance with previous 
findings of a negative correlation between IBDs' 
activity and the participants' QoL,11-16 predictive value 
of psychological disturbances for a lower QoL,22-23 and 
independent contribution of disease activity and 
psychological disturbances in explaining the variance 
of HRQoL.12 A somewhat lower predictive value of 
depression is probably the consequence of the well-
known effect of overlapping of clinical elements and 
high correlation between anxiety and depression. 
Although male gender and income were predictive 
for HRQoL in the first model, when analyzing the 
contribution of socio-demographic factors only, their 
predictive value was not significant in the final model, 
probably due to negative correlations between male 
gender and anxiety, and between income and disease 
activity, anxiety and depression. This suggests that 
psychological disturbances and disease activity could 
be mediators in explaining the correlations of gender 
and income with HRQoL. A well-documented lower 
prevalence of anxiety in men beneficially influences 
the HRQoL in male subjects. As for the income, apart 
from a simple explanation that IBDs' activity and 
accompanying psychological disturbances may 
represent significant limitations in earning, it is 
possible that subjects with higher income experience 
fewer existential problems which can be a prominent 
trigger of psychological stress, which in turn lowers the 
HRQoL. It is also possible that subjects with a higher 
income have better financial opportunities for 
managing the IBDs' activity and accompanying 
psychological disturbances, as well as adopting a more 
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suitable lifestyle. Age was not predictive for HRQoL, 
consistent with Hauser’s22 findings. Although a low 
positive correlation of illness duration with problem-
focused coping (r = 0 .18; p < 0 .05) could mean that 
with time subjects learn to cope with clinical 
manifestations of the disease in a more active and 
better way, the fact that there was no correlation 
between illness duration and QoL suggests that the 
frequency of relapses and the intensity of the disease, 
as well as possible adaptations of one's lifestyle to the 
limitations of the disease, have far more influence on 
quality of life than the illness duration itself.  
Although the perceived social support and 
problem-focused coping with stress were positively, 
and disengagement negatively correlated with QoL, 
they did not significantly contribute to further increase 
in explained variance of HRQoL. This could be due to 
coping as a possible mediator of the impact of mood 
on QoL in IBD. As perceived social support and 
problem-focused coping were negatively and 
disengagement positively correlated with anxiety and 
depression, participants with lower levels of anxiety 
and depression could perceive the social support they 
receive as higher and use constructive strategies of 
coping with the disease more frequently, thus 
increasing their QoL. Both our findings and those from 
a previous study102 that coping strategies did not 
independently predict QoL in patients with IBD after 
illness perceptions were controlled for, support this 
explanation of the relationship between psychological 
distress, coping and QoL in IBD, with mood as the 
primary determinant of QoL and coping as a mediator. 
Alternatively, the perceived social support and 
problem-focused coping could lead to the reduction of 
anxiety and depression, while disengagement could 
enhance them, thus indirectly influencing the QoL. In 
line with this notion, there is evidence of the 
effectiveness of self-management interventions in IBD 
in improving psychological well-being and healthcare 
resource use and reducing symptom reporting.103-104 
Moreover, when interpreting the role of coping 
strategies, we must take into consideration the low 
reliability of the questionnaire used so that this study 
does not allow any firm conclusions about the role of 
coping strategies in the QoL. 
The findings of independent contribution of 
psychological disturbances in predicting the quality of 
life, positive correlation of anxiety and depression with 
disease activity, a high percentage of clinically 
relevant anxiety and depression among subjects 
suffering from IBD with both active and inactive 
disease, and overall findings on bidirectional relation 
between the symptoms of IBD and psychological 
disturbances have important clinical implications. 
Taken together, they suggest the need for a routine 
screening for anxiety and depression in IBD patients 
with both active and inactive disease and specific 
psychological support directed towards anxiety and 
depression management for subjects with IBD.   
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